Study on lung cancer spread
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how lung cancer spreads in people with early-stage non-small cell lung cancer. It may help doctors better understand the disease and improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with stage 1A to stage 3A non-small cell lung cancer that can be removed with surgery
- Your cancer type is adenocarcinoma or squamous cell carcinoma
- You are healthy enough for surgery or a combination of treatments
- You agree to have surgery as part of your treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks for cancer cells that travel through the blood or spread through air spaces in the lungs of people with early-stage lung cancer. The goal is to understand how these cells affect the disease, and it may help doctors plan better treatment in the future.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This study looks at how lung cancer changes over time by analyzing tumor tissue and blood. It may help researchers understand what drives cancer relapse after early-stage surgery.
This study looks for biological markers (signs in blood or tissue) that predict how early-stage lung cancer spreads. If you have recently diagnosed lung cancer, this research could help doctors better understand your cancer and plan better treatments.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
Hear when a new Oncology & Epidemiology & Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.